Previous close | 0.2000 |
Open | 0.1000 |
Bid | 0.0000 |
Ask | 0.0500 |
Strike | 15.00 |
Expiry date | 2024-05-17 |
Day's range | 0.1000 - 0.2000 |
Contract range | N/A |
Volume | |
Open interest | 16 |
NEW YORK and SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company discovering and developing clinically differentiated small molecule therapeutics targeting fundamental biological pathways of cancers, today announced that members of the management team will participate in a virtual fireside chat during the TD Cowen 5th Annual Oncology Innovation Summit: Insights for ASCO and EHA on May 28, 2024 at 10:30 a.m. ET. Ac
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
Insight into Zentalis Pharmaceuticals' Financial Health and Future Outlook